Difficulty: Medium
Average Score: 73%
Practice
A 24-year-old male comes to the clinic complaining of vague abdominal pain, headaches, sweating, and unintentional weight loss. Urinalysis reveals elevated levels of catecholamine metabolites. Which of the following is a metabolite specific to the breakdown of epinephrine?
Correct answer
D
Rationale
The correct answer is D) Metanephrine. In this scenario, the patient is likely experiencing symptoms of a catecholamine-secreting tumor, such as a pheochromocytoma, which results in the increased breakdown of catecholamines like epinephrine. Metanephrine is a metabolite specific to the breakdown of epinephrine, making it the most relevant choice.
Option A) Dihydroxyphenylalanine (DOPA) is an intermediate in the synthesis of catecholamines like dopamine, norepinephrine, and epinephrine, not a metabolite of epinephrine breakdown.
Option B) Dihydroxymandelic acid is a metabolite of norepinephrine breakdown, not epinephrine.
Option C) Homovanillic acid is a metabolite of dopamine breakdown, not epinephrine.
Understanding the metabolites specific to the breakdown of different catecholamines is crucial in diagnosing conditions like pheochromocytoma. This knowledge helps healthcare providers interpret test results accurately and provide appropriate treatment. It also highlights the importance of recognizing the distinct metabolic pathways of different neurotransmitters and hormones in pharmacology and clinical practice.
Option A) Dihydroxyphenylalanine (DOPA) is an intermediate in the synthesis of catecholamines like dopamine, norepinephrine, and epinephrine, not a metabolite of epinephrine breakdown.
Option B) Dihydroxymandelic acid is a metabolite of norepinephrine breakdown, not epinephrine.
Option C) Homovanillic acid is a metabolite of dopamine breakdown, not epinephrine.
Understanding the metabolites specific to the breakdown of different catecholamines is crucial in diagnosing conditions like pheochromocytoma. This knowledge helps healthcare providers interpret test results accurately and provide appropriate treatment. It also highlights the importance of recognizing the distinct metabolic pathways of different neurotransmitters and hormones in pharmacology and clinical practice.